Showing results (391-400 of 1,894) with videos related to
Sort By:
Pageof 190
Alzheimer Disease and Associated Disorders|June 12, 2012
Body height and late-life cognition among patients with atherothrombotic diseaseGalit Weinstein, Uri Goldbourt, David TanneAlzheimer Disease and Associated Disorders|July 25, 2015
A systematic review of the public's knowledge and understanding of Alzheimer's disease and dementiaSuzanne Cahill, Maria Pierce, Perla Werner, et al.Alzheimer Disease and Associated Disorders|January 1, 1988
Serum IgG brain reactive antibodies in Alzheimer disease and Down syndromeM Kumar, D Cohen, C EisdorferAlzheimer Disease and Associated Disorders|April 27, 2018
Effects of the Tailored Activity Program in Brazil (TAP-BR) for Persons With Dementia: A Randomized Pilot TrialMarcia M P C Novelli, Styfany C B Machado, Gabriela B Lima, et al.Alzheimer Disease and Associated Disorders|May 25, 2017
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover StudyAaron M Koenig, Dawn Mechanic-Hamilton, Sharon X Xie, et al.Alzheimer Disease and Associated Disorders|July 20, 2018
Improved Gray Matter Atrophy Detection in Alzheimer Disease in Chinese Populations Using Chinese Brain TemplateXiuqin Jia, Lin Shi, Tianyi Qian, et al.Alzheimer Disease and Associated Disorders|December 1, 2005
Psychiatric symptoms and their psychosocial consequences in frontotemporal dementiaUlla Passant, Christina Elfgren, Elisabet Englund, et al.Alzheimer Disease and Associated Disorders|December 1, 2005
Frontotemporal dementia: one disease, or many?: probably one, possibly twoAndrew KerteszAlzheimer Disease and Associated Disorders|January 1, 1997
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative StudyS H Ferris, J A Mackell, R Mohs, et al.Alzheimer Disease and Associated Disorders|January 1, 1997
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative StudyR C Mohs, D Knopman, R C Petersen, et al.Pageof 190